Abstract 743: Detection of TERT C228T and C250T promoter mutations in melanoma tumor and plasma samples using novel mutation-specific droplet digital PCR assays
Broderick C. Corless(Cornell University), David Polsky(New York University), Samantha Cooper(Bio-Rad (United States)), Iman Osman(New York University), Gregory Chang(NYU Langone Health), George Karlin‐Neumann(Bio-Rad (United States)), Mahrukh M. Syeda(NYU Langone Health)
Cited by 1
Related Papers
High-Throughput Droplet Digital PCR System for Absolute Quantitation of DNA Copy Number
|Analytical Chemistry|2011|2.8k
BRAF mutation predicts sensitivity to MEK inhibition
|Nature|2005|1.3k
Cancer cell states recur across tumor types and form specific interactions with the tumor microenvironment
|Nature Genetics|2022|527
Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Metastatic Melanoma
|Clinical Cancer Research|2008|188
Using Machine Learning Algorithms to Predict Immunotherapy Response in Patients with Advanced Melanoma
|Clinical Cancer Research|2020|177